(Q37597583)

21 August 2017

title

Cancer, cyclo-oxygenase and nonsteroidal anti-inflammatory drugs - can we combine all three? (English)

1 reference

21 August 2017

0 references

A Hayes

1

1 reference

21 August 2017

publication date

1 March 2007

1 reference

Veterinary and Comparative Oncology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

1-13

1 reference

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

21 January 2018

Cyclooxygenase-2 Biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Rofecoxib reduces polyp recurrence in familial polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Prostaglandin E2 concentrations in naturally occurring canine cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Expression of cyclooxygenase-2 in canine epithelial nasal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

COX-1 and COX-2 expression in feline oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

Aspirin and the Risk of Colorectal Cancer in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5829.2006.00111.X

10.1111/J.1476-5829.2006.00111.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference